Literature DB >> 11193027

Heat shock protein 70 is required for the survival of cancer cells.

J Nylandsted1, K Brand, M Jäättelä.   

Abstract

The major stress-inducible heat shock protein, Hsp70, is a chaperone protein abundantly and preferentially expressed in human tumors and tumor cell lines. Owing to the ability of Hsp70 to protect cells from a wide range of apoptotic and necrotic stimuli, it has been assumed that Hsp70 may confer survival advantage to tumor cells. To investigate this hypothesis in human tumor cell lines, we generated an adenovirus expressing antisense Hsp70 (Ad.asHsp70). The effective and specific depletion of Hsp70 by Ad.asHsp70 resulted in massive cell death of all tumorigenic cell lines tested (carcinomas of breast, colon, prostate and liver as well as glioblastoma). In spite of an effective depletion of Hsp70, Ad.asHsp70 had no effect on the survival or growth of fetal fibroblasts or non-tumorigenic epithelial cells of breast or prostate. Anti-apoptotic proteins Bcl-2, Bcl-XL and CrmA as well as peptide-inhibitors of caspases, DEVD-CHO and zVAD-FMK, failed to rescue tumor cells from Ad.asHsp70-induced cell death. These results indicate that the high expression of Hsp70 is a prerequisite for the survival of human cancer cells of various origins and reveal Hsp70 as the only protein described so far whose expression is specifically needed for the survival of tumorigenic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193027     DOI: 10.1111/j.1749-6632.2000.tb05605.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  61 in total

Review 1.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 2.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

3.  The role of stress proteins in prostate cancer.

Authors:  Alan So; Boris Hadaschik; Richard Sowery; Martin Gleave
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

4.  Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression.

Authors:  Lei Zhao; B O Jiang; Dong Wang; Wei Liu; Huawu Zhang; Weisheng Liu; Zhen Qiu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

5.  Backbone and methyl resonance assignments of the 42 kDa human Hsc70 nucleotide binding domain in the ADP state.

Authors:  Erik R P Zuiderweg; Jason E Gestwicki
Journal:  Biomol NMR Assign       Date:  2016-10-03       Impact factor: 0.746

6.  Differential heat shock protein localization in chronic lymphocytic leukemia.

Authors:  Nina C Dempsey; Francesca Leoni; H Elyse Ireland; Christine Hoyle; John H H Williams
Journal:  J Leukoc Biol       Date:  2009-12-10       Impact factor: 4.962

7.  Hsp72 chaperone function is dispensable for protection against stress-induced apoptosis.

Authors:  Ari M Chow; Rohan Steel; Robin L Anderson
Journal:  Cell Stress Chaperones       Date:  2008-09-26       Impact factor: 3.667

8.  Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol.

Authors:  Juliana de Saldanha da Gama Fischer; Lujian Liao; Paulo C Carvalho; Valmir C Barbosa; Gilberto B Domont; Maria da Gloria da Costa Carvalho; John R Yates
Journal:  J Proteomics       Date:  2010-01-18       Impact factor: 4.044

9.  Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitors.

Authors:  Sailesh Gopalakrishna-Pillai; Linda E Iverson
Journal:  BMC Med Genomics       Date:  2010-04-27       Impact factor: 3.063

10.  Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.

Authors:  Phan L C H B Tran; Soo-A Kim; Hong Seok Choi; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  BMC Cancer       Date:  2010-06-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.